Acessibilidade / Reportar erro

Therapy with infliximab in active Behçet's disease

The authors describe the case of a 41 years old woman with the diagnosis of Behçet's syndrome since April 2000, when she presented mucocutaneous, articular and ocular manifestations. The disease remained active despite of the treatment with colchicine, corticosteroid and methotrexate, during the three years following diagnosis. In April 2003, the patient still needed high doses of corticosteroid and methotrexate. Nevertheless, the disease remained active. Treatment with infliximab was then started with intravenous 3 mg/Kg and, one week later, all the manifestations of this patient were in complete remission.

Behçet's disease; infliximab; treatment


Sociedade Brasileira de Reumatologia Av Brigadeiro Luiz Antonio, 2466 - Cj 93., 01402-000 São Paulo - SP, Tel./Fax: 55 11 3289 7165 - São Paulo - SP - Brazil
E-mail: sbre@terra.com.br